Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00345-022-03961-0 | DOI Listing |
Cancer Cytopathol
February 2025
Department of Pathology, Stanford University School of Medicine, Stanford, California, USA.
Background: Fumarate hydratase-deficient renal cell carcinoma (FHRCC) is an aggressive carcinoma that typically presents as advanced-stage disease. Prompt recognition of FHRCC is critical for appropriate clinical care and genetic counseling for patients and family members. However, diagnosing FHRCC from cytology specimens is challenging, with limited characterization and no reports describing prospectively identified cases.
View Article and Find Full Text PDFFront Oncol
November 2024
Department of Breast, The Third Affiliated Hospital of Beijing University of Chinese Medicine, Beijing, China.
Zhonghua Zhong Liu Za Zhi
November 2024
Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing100021, China.
Sci Rep
November 2024
Department of Ultrasonic, Shanxi Provincial People's Hospital, 29 shuangtaisi street, yingze district, Taiyuan, Shanxi, 030001, China.
Cancer Imaging
November 2024
Department of Ultrasonography, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China.
Objective: The aim of this study was to establish an ensemble learning model based on clinicopathological parameter and ultrasound radomics for assessing the risk of lateral cervical lymph node with short diameter less than 8 mm (small lymph nodes were used instead) metastasis in patients with papillary thyroid cancer (PTC), thereby guiding the selection of surgical methods.
Methods: This retrospective analysis was conducted on 454 patients diagnosed with papillary thyroid carcinoma who underwent total thyroidectomy and lateral neck lymph node dissection or lymph node intraoperative frozen section biopsy at the First Hospital of China Medical University between January 2015 and April 2022. In a ratio of 8:2, 362(80%) patients were assigned to the training set and 92(20%) patients were assigned to the test set.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!